National Drug Code (NDC) Database
Sterling S.p.A.
-
NDC:
64918-1901
-
Nonproprietary Name:
DEFLAZACORT
-
Dosage Form:
POWDER
-
Product Type:
BULK INGREDIENT
-
Strength:
1 kg/kg
-
Substance:
DEFLAZACORT
-
Start Marketing Date:
2014-10-30
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Steroid S.p.A.
-
NDC:
49803-013
-
Nonproprietary Name:
Estradiol Valerate
-
Dosage Form:
POWDER
-
Product Type:
BULK INGREDIENT
-
Strength:
25000 g/25000g
-
Substance:
ESTRADIOL VALERATE
-
Start Marketing Date:
2024-02-13
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
STHREE CHEMICALS PRIVATE LIMITED
-
NDC:
83511-041
-
Nonproprietary Name:
Gatifloxacin
-
Dosage Form:
POWDER
-
Product Type:
BULK INGREDIENT
-
Strength:
35 kg/35kg
-
Substance:
GATIFLOXACIN
-
Start Marketing Date:
2026-05-26
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2027-12-31
-
NDC:
50711-0014
-
Nonproprietary Name:
4-Methylpyrazole
-
Dosage Form:
INJECTION
-
Product Type:
BULK INGREDIENT
-
Strength:
1 g/g
-
Substance:
FOMEPIZOLE
-
Start Marketing Date:
2023-12-18
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Strides Shasun Limited
-
NDC:
64380-001
-
Nonproprietary Name:
ibuprofen
-
Dosage Form:
POWDER
-
Product Type:
BULK INGREDIENT
-
Strength:
1 kg/kg
-
Substance:
IBUPROFEN
-
Start Marketing Date:
1997-09-23
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Strive Pharmaceuticals Inc
-
NDC:
70692-795
-
Nonproprietary Name:
Pamabrom
-
Dosage Form:
CAPSULE, LIQUID FILLED
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
50 mg/1
-
Substance:
PAMABROM
-
Start Marketing Date:
2020-11-30
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Suanfarma Italia S.p.A
-
NDC:
55073-0400
-
Nonproprietary Name:
Tiamulin Hydrogen Fumarate
-
Dosage Form:
POWDER
-
Product Type:
BULK INGREDIENT
-
Strength:
10 kg/10kg
-
Substance:
TIAMULIN FUMARATE
-
Start Marketing Date:
2009-12-07
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
SUCAMPO PHARMA LIMITED LIABILITY COMPANY
-
NDC:
13299-0104
-
Nonproprietary Name:
Lubiprostone Premix
-
Dosage Form:
SOLUTION, CONCENTRATE
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
24 mg/g
-
Substance:
LUBIPROSTONE
-
Start Marketing Date:
2010-04-01
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2027-12-31
-
NDC:
64918-5930
-
Nonproprietary Name:
ORFORGLIPRON HEMICALCIUM HYDRATE
-
Dosage Form:
POWDER
-
Product Type:
BULK INGREDIENT
-
Strength:
1 kg/kg
-
Substance:
ORFORGLIPRON HEMICALCIUM MONOHYDRATE
-
Start Marketing Date:
2026-04-22
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2027-12-31
-
NDC:
49803-009
-
Nonproprietary Name:
Boldenone Undecylenate
-
Dosage Form:
LIQUID
-
Product Type:
BULK INGREDIENT
-
Strength:
1 g/g
-
Substance:
BOLDENONE UNDECYLENATE
-
Start Marketing Date:
2020-02-18
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
CIII
-
Certified Through:
2026-12-31
Create a New Buying Request
Fields marked with * are mandatory.